Urologist Ján Švihra, Jr. (source: SME - Jozef Jakubčo)
In Europe, prostate cancer is the most common oncological disease in men, and makes up to 20 percent of all male cancer patients. Slovak men are no exception. And even though the disease can be treated with success if diagnosed early, approximately one out of 10 patients in Slovakia unnecessarily dies from prostate cancer.
It would not be like this if men regularly visited a urologist.
"For many it's still difficult to understand that they should come for a prostate examination after 50 at the latest, even if they don't have any urological problems," urologist Ján Švihra, Jr. tells the Slovak Spectator.
Together with his colleagues from Comenius University's Jessenius Faculty of Medicine in Martin, he is part of an international team. Their goal is to improve treatment.
Their research was published in the journal Frontiers in Oncology.
To stay up to date with what scientists in Slovakia or Slovak scientists around the world are doing, subscribe to the Slovak Science newsletter, which will be sent to readers free of charge four times a year.
